SOURCE: Xtalks

Xtalks Webinars

March 09, 2016 07:00 ET

Webinar to Examine Rare Oncology Research in the 21st Century

TORONTO, ON --(Marketwired - March 09, 2016) - Premier Research presents an exciting live webinar on Tuesday, March 29, 2016, highlighting some of the challenges in designing and conducting trials for rare cancers. Additionally, the speakers will be exploring positions adopted by various authors and research consortia on how to best design and conduct these trials, including a review of pending legislation -- the 21st Century Cures Act -- and how it might affect rare oncology research if passed.

Considerations include recruiting patients with rare cancers, maximizing the value of data points in clinical trials involving small populations, potential use of adaptive design in these trials, and the appetite for risk among researchers and patients.

Typically in oncology trials, and similarly in rare disease trials, the investigational product is tested only on affected subjects rather than on healthy volunteers. Testing new drugs on this vulnerable population requires consideration of the study design so the fewest possible subjects are exposed to the investigational product, and so the study yields information that supports viable research decisions.

As the cost of clinical trials rises along with the cost of bringing new drugs to market, research should include alternative study design approaches and emphasize early indicators such as biomarkers, natural history data, and preclinical data. This approach also reduces the patient burden and may accelerate drug development timelines.

For more information about this complimentary event, visit: http://www.xtalks.com/Rare-Oncology-Research-21st-Century.ashx

About Premier Research

Premier Research is a leading contract research organization serving the needs of biotechnology, pharmaceutical, and medical device companies worldwide. The company has a wealth of experience in the execution of global, regional, and local clinical development programs, with a special focus on addressing unmet needs in areas such as analgesia, CNS, rare diseases, medical device and diagnostics, oncology, and pediatric research. Premier Research operates in 84 countries and employs more than 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. With its mission to improve productivity in clinical development, the company aligns itself with the mission of its customers to bring new medical treatments to patients promptly, accurately, and cost-effectively.

To learn more about Premier Research visit: premier-research.com

About Xtalks

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2016/3/8/11G086638/Images/Premier_Research_logo-398906951265.jpg

Contact Information